Concepedia

Lauren Price

LP

13

Publications

2.4K

Citations

13

H-Index

1995

Active since

Affiliations

United States Food and Drug Administration(Current)

University of Washington

Center for Drug Evaluation and Research

UNC Lineberger Comprehensive Cancer Center

UNC/NCSU Joint Department of Biomedical Engineering

Lauren Price is an author at United States Food and Drug Administration specializing in medicine, pharmacology, and pharmacotherapy.

ORCID

Top concepts

Publications per year

1995–2023

13

Publications

13

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.7K citations · Full text

, , +6

FDA Approval Summary: Selpercatinib for the Treatment of Lung and Thyroid Cancers with <i>RET</i> Gene Mutations or Fusions

Diana Bradford, Erin Larkins, Sirisha L. Mushti et al. · Clinical Cancer Research · 2020 · 161 citations

A reanalysis of nanoparticle tumor delivery using classical pharmacokinetic metrics

Lauren Price, Stęphan T. Stern, Allison M. Deal et al. · Science Advances · 2020 · 110 citations · Full text

Overcoming anti-PEG antibody mediated accelerated blood clearance of PEGylated liposomes by pre-infusion with high molecular weight free PEG

Morgan D. McSweeney, Lauren Price, Timothy Wessler et al. · Journal of Controlled Release · 2019 · 82 citations

, , +9

A minimal physiologically based pharmacokinetic model that predicts anti-PEG IgG-mediated clearance of PEGylated drugs in human and mouse

Morgan D. McSweeney, Timothy Wessler, Lauren Price et al. · Journal of Controlled Release · 2018 · 79 citations

, , +7

Rows per page

1–5 of 13